| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |